Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G SAQsAntenatal care — maternal immunisation

O&G SAQs · Antenatal care — maternal immunisation

Vaccination in pregnancy — structured SAQ (15 marks)

FRANZCOG-format structured SAQ on vaccination in pregnancy: the four recommended vaccines with timing, transplacental IgG transfer physiology, the contraindicated live vaccines, and the management of the rubella-seronegative woman. Per-sub-part marking rubric included.

15 marks20 min3 min readVerification in progress

Target exams

FRANZCOGMRCOGABOG
On this page
Study tools

Target exams

FRANZCOGMRCOGABOG
Prompt
You are the antenatal clinic registrar. A 28-year-old woman attends her first antenatal visit at 11 weeks gestation. She is well, with a normal booking assessment. (a) Name the four vaccines routinely recommended in pregnancy in Australia, and state the recommended timing and whether each is repeated every pregnancy. (5 marks) (b) Explain the mechanism by which maternal vaccination protects the newborn, and why the timing of pertussis and RSV vaccination is set in the late second to third trimester. (3 marks) (c) List the vaccines contraindicated in pregnancy and explain why. (3 marks) (d) Her booking serology returns rubella IgG negative. Outline your management, including what you will and will not do during pregnancy and postpartum. (4 marks)

How this SAQ is marked

Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: the named vaccines, their timing, the contraindicated live vaccines, and the mechanism. Write in short labelled points, not prose paragraphs. Answer the sub-part you are asked. [4]

Reveal model answer and mark schemeShowHide

(a) The four routinely recommended vaccines (5 marks)

One mark each for the first four (vaccine + timing + every-pregnancy), one mark for the overall principle. [4]

  • Influenza (inactivated): any stage of each pregnancy, seasonal. Repeated every pregnancy.[1]
  • Pertussis (dTpa): 20 to 32 weeks gestation (ANZ/ATAGI). Repeated every pregnancy.[2]
  • RSV (Abrysvo, bivalent prefusion F): from 28 weeks gestation (ANZ), single dose, seasonal. Each pregnancy (where in season).[3]
  • COVID-19: per current ATAGI/ACOG guidance. Recommended in pregnancy.[5]
  • Principle: pertussis and RSV are given each pregnancy because antibody wanes between pregnancies and each infant needs a fresh antibody load transferred close to birth.[4]

(b) Mechanism and timing rationale (3 marks)

One mark for the dual mechanism, one for IgG transfer physiology, one for the timing rationale. [4]

  • Dual mechanism: maternal vaccination protects the mother directly (active immunity) and the infant via passive transfer of maternal antibody.
  • IgG transfer: maternal IgG crosses the placenta via the neonatal Fc receptor (FcRn); transfer is minimal early and accelerates sharply in the third trimester, so a term infant is born with antibody concentrations that often exceed the mother's.
  • Timing rationale: pertussis (20 to 32 weeks) and RSV (28 to 36 weeks) are timed for the late second to third trimester so there is enough time for a robust maternal antibody response and maximal transfer before birth. Vaccinate too early and antibody wanes before peak transfer; too late and the infant is born before transfer is complete.[4]

(c) Contraindicated vaccines and why (3 marks)

One mark for naming them, one for the type, one for the rationale. [4]

  • Live-attenuated vaccines contraindicated in pregnancy: MMR, varicella, BCG, live-attenuated influenza (LAIV), and yellow fever (unless risk unavoidable).
  • These are live-attenuated vaccines — the organism replicates.
  • Rationale: theoretical risk of fetal infection from the replicating organism. Documented harm is rare, but the precaution stands. If a live vaccine is given inadvertently, reassure and document — termination is not recommended for the vaccine alone.[4]

(d) Rubella-seronegative management (4 marks)

One mark for NOT giving MMR in pregnancy; one for the postpartum plan; one for breastfeeding/avoidance counselling; one for documenting and the rationale. [4]

  • Do NOT administer MMR during pregnancy — it is live and contraindicated. (The reflex error is to give it; do not.)
  • Defer MMR to the postpartum period — administer it before discharge from hospital.[4]
  • Counsel: MMR is safe in breastfeeding; advise the woman to avoid pregnancy for one month after the dose.
  • Document the seronegative status and the postpartum plan. Rationale: primary rubella infection in early pregnancy causes congenital rubella syndrome, so immunity matters and the postpartum catch-up is essential.[4]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants N Engl J Med, 2008.PMID 18799552
  2. [2]Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013 Clin Infect Dis, 2015.PMID 25332078
  3. [3]Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants N Engl J Med, 2023.PMID 37018474
  4. [4]American College of Obstetricians and Gynecologists ACOG Committee Opinion No. 741: Maternal Immunization Obstet Gynecol, 2018.PMID 29794683
  5. [5]Morgan JA, Biggio JR Jr, Martin JK, et al. Pregnancy Outcomes in Patients After Completion of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccination Obstet Gynecol, 2023.PMID 36735413
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousUrodynamics — structured SAQ (15 marks)Urogynaecology — lower urinary tract evaluationNextVaginal breech birth — structured SAQ (15 marks)Intrapartum care — malpresentation and operative birth